Affiliation:
1. Londrina State University
2. Micropar Private Laboratory
3. Cancer Hospital of Londrina - HCL
Abstract
Abstract
Purpose
Metastasis represents the major cause of deaths in cancer patients, and the tumor surrounding extracellular matrix (ECM) passes through changes in its organization during the evolution of this process. Therefore, the aim of the present study was to quantify the deposition of proteins that constitute the ECM, namely total collagen, collagen I (Col I) and collagen III (Col III) in samples from patients with metastatic (mPCa) and non-metastatic prostate cancer (PCa), in addition of evaluating the basement membrane integrity.
Methods
Tissue samples from 60 patients were divided into three groups according to parameters ISUP grade, TNM staging and PSA concentration: better prognosis (n = 20), worse prognosis (n = 23) and metastatic (n = 17). To quantify collagen, the Picrosirius Red technique was used with further analysis under a polarization microscope, and to basement membrane analysis the Periodic Acid Schiff (PAS) technique was employed, where the coloring was classified in G1, G2 and G3.
Results
It was observed that the Col I/ Col III ratio was higher in the metastatic group in relation to better prognosis (p = 0.012) and worse prognosis (p = 0.018) groups. About the basement integrity, it was observed that its constitution in the malignant tumor tissue differed from the adjacent non-tumor tissue (p = 0.000). Also, the worsening in the tumor tissue integrity was positively correlated with worse prognosis parameters (advanced ISUP grade, extraprostatic extension and perineural invasion).
Conclusion
Our study indicates that the absence of Col III can constitute a marker for potential metastatic tumors. The basement membrane integrity also seems to be an indicator of poor prognosis in malignant prostatic tumors.
Publisher
Research Square Platform LLC
Reference42 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;CA: a cancer journal for clinicians.,2021
2. INCA, Instituto Nacional do Câncer. Ministério da Saúde. Brasil - estimativa dos casos novos [Internet]. https://www.inca.gov.br/estimativa/estado-capital/brasil Accessed 28 September 2022
3. Sociedade Brasileira de Urologia (2018) Nota oficial SBU e SBPC/ML – Rastreio de Câncer de Próstata [Internet]. https://portaldaurologia.org.br/medicos/noticias/nota-oficial-sbu-e-sbpc-ml-rastreio-de-cancer-de-prostata/. Accessed 12 August 2022
4. Screening for prostate cancer: US Preventive Services Task Force recommendation statement;Grossman DC;Jama.,2018
5. Prostate cancer in primary care;Merriel SW;Adv. therapy,2018